Skip to product information
1 of 1

RAW MIT

CHERRY LIME SLUSH - C9 - 50MGS

CHERRY LIME SLUSH - C9 - 50MGS

Regular price $12.00 USD
Regular price Sale price $12.00 USD
Sale Sold out
Quantity

DISCLAIMER: This product has not been evaluated by the Food and Drug Administration (FDA). It is not intended to diagnose, treat, cure, or prevent any disease.

CHERRY LIME SLUSH πŸ’πŸ‹πŸŸ© - C9 (9-Hydroxycorynantheidine) - 50MG

DEBUT RELEASE - 06.10.26

C9 was originally released as a limited sample run in Birthday Cake to gather real-world feedback from the RAW community. The response exceeded our expectations, with many customers requesting that it become a permanent part of our lineup. Based on that feedback, we decided to make C9 an official RAW release.

One of the most common pieces of feedback we received was that customers viewed C9 as being in a lane of its own. Rather than comparing it to other alkaloids, many users described it as having a unique profile that earned a place in their routine for entirely different reasons.

While experiences vary from person to person, customers frequently described C9 as something they reached for later in the day or as part of their evening routine. Others preferred incorporating it alongside their existing stack rather than viewing it as a replacement for anything else.

WHAT IS C9?

C9 (9-Hydroxycorynantheidine) is an indole alkaloid derivative based on corynantheidine, a naturally occurring alkaloid found in select botanical sources.

Corynantheidine belongs to a family of indole alkaloids related to corynanthine. Corynanthine has been described as an alpha adrenoceptor antagonist with a higher affinity for alpha-1 adrenoceptors than alpha-2 adrenoceptors, making it distinct from many other naturally occurring alkaloids.

C9 is an alkaloid derivative built on a Corynanthe-type framework known to interact with opioid receptors, primarily mu receptors, as a partial agonist, meaning it engages the receptor without fully activating it, resulting in a more moderated response.

The "9-hydroxy" designation refers to a small structural change on the molecule, where a hydroxyl (-OH) group is present at the 9 position. Even minor changes like this can influence how a compound behaves compared to its original form.

C9 is produced at the alkaloid level rather than consumed as raw plant material, meaning it is not dependent on kratom leaf itself as a finished product.

View full details